设计质量
关键质量属性
析因实验
分散性
粒径
固化(化学)
材料科学
中心组合设计
聚合物
色谱法
工艺工程
生物医学工程
计算机科学
化学工程
纳米技术
化学
响应面法
复合材料
工程类
高分子化学
机器学习
作者
Asta-Ramaha Synthia Mackin-Mohamour,Julia Budzinski,Thierry Bastogne,Thibault Roques‐Carmes,Véronique Sadtler,Philippe Marchal,Anne Sapin‐Minet,Marianne Parent
标识
DOI:10.1016/j.colsurfa.2024.134053
摘要
The development of alginate microparticles for encapsulation of hydrophilic drug is addressed. The alginate microparticles are produced by the emulsification/gelation process. The objective of this study is to optimize the encapsulation of sunset yellow, a model of small hydrophilic drug, by the means of an agile quality by design (QbD) approach. Five input factors are considered: the alginate concentration (2-7% w/V), the drug/polymer ratio (0.1/1-0.5/1), the cross-linker addition flow rate (1-1.6 mL/min), the cross-linker volume (5-10 mL), and the crosslinking time (15-60 min). Critical quality attributes (and their associated specifications) are the particle size (∈30;150µm) and polydispersity, the encapsulation efficiency (>50%), and the drug loading (>10%). The implemented agile method follows three successive QbD sprints, each based on a specific design of experiments (DoE). First, a screening of the process parameters is performed using a Plackett-Burman design, followed in a second sprint by the implementation of a central composite Hartley’s design to identify the design space and to extract four eligible control operating regions where the probability to meet the CQA specifications is above 95%. In the last sprint, one of these optimal operating conditions has been qualified by testing eight end points of the region through the application of a full factorial design. This operating region corresponds to a combination of three factors: alginate concentration in [6.7;7]%, drug/polymer ratio in [0.29;0.34]w/w and a curing time in [40;60]min.
科研通智能强力驱动
Strongly Powered by AbleSci AI